Charles River Laboratories International (CRL) Cash from Operations (2016 - 2025)
Charles River Laboratories International has reported Cash from Operations over the past 17 years, most recently at 147520000.0 for Q4 2025.
- Quarterly results put Cash from Operations at 147520000.0 for Q4 2025, down 7.43% from a year ago — trailing twelve months through Dec 2025 was 737646000.0 (changed 0.42% YoY), and the annual figure for FY2025 was 737646000.0, changed 0.42%.
- Cash from Operations for Q4 2025 was 147520000.0 at Charles River Laboratories International, down from 213826000.0 in the prior quarter.
- Over the last five years, Cash from Operations for CRL hit a ceiling of 251792000.0 in Q3 2024 and a floor of 102630000.0 in Q1 2022.
- Median Cash from Operations over the past 5 years was 173209500.0 (2021), compared with a mean of 176828000.0.
- Biggest five-year swings in Cash from Operations: skyrocketed 148.18% in 2021 and later plummeted 39.71% in 2022.
- Charles River Laboratories International's Cash from Operations stood at 229258000.0 in 2021, then increased by 2.4% to 234757000.0 in 2022, then dropped by 5.88% to 220943000.0 in 2023, then dropped by 27.87% to 159362000.0 in 2024, then decreased by 7.43% to 147520000.0 in 2025.
- The last three reported values for Cash from Operations were 147520000.0 (Q4 2025), 213826000.0 (Q3 2025), and 204603000.0 (Q2 2025) per Business Quant data.